Genome Medical Wins “Genomics Innovation Award” in 7th Annual MedTech Breakthrough Awards Program

International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Innovations

SOUTH SAN FRANCISCO, Calif., – May 3, 2023Genome Medical, the leading telehealth provider of genetic services and genomics-based care, today announced that its RISE Risk Assessment Module is the recipient of the “Genomics Innovation Award” in the 7th annual MedTech Breakthrough Awards program. MedTech Breakthrough is an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market.

The RISE Risk Assessment Module: Hereditary Cancer is a patient-administered digital tool that has been clinically validated using genetic testing criteria based on national guidelines to identify individuals who may benefit from cancer genetic testing. RISE collects and analyzes family and personal health history on any personal device with internet access. Completing the assessment is made easy for patients and providers – with a link sent via text, email or QR code – and takes less than five minutes to complete. Patients can also be prompted to schedule an appointment with a Genome Medical genetic counselor.

Additionally, patients who are identified via the RISE assessment are provided with pre-test education content related to their hereditary cancer risk. This better prepares them for their appointment with a Genome Medical genetic counselor and reduces the burden on providers to ensure their patients receive accurate information about their genetic test options.

The RISE risk assessment for hereditary cancer completion rate is greater than 95% and on average, 26% of patients screened have met national guidelines that indicate they would benefit from genetic services. Providers can point their patients to RISE for a guidelines-based process that could improve compliance, save physician time and improve patient screening.

“This award highlights the work we are doing to support healthcare providers and their patients. Genomic medicine is critical to the prevention, diagnosis and treatment of inherited disease, yet most people who would benefit don’t have access,” said Jill Davies, CEO, Genome Medical. “RISE was developed to provide clinicians with the capability to dramatically increase access to genetic services and support patient decision-making without adding operational burden to their practice.”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Telehealth, Genomics, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data and many more. This year’s program attracted more than 4,000 nominations from over 17 different countries throughout the world.

“Knowledge of genetic and genomic risk factors is important for many areas of medicine where early identification for at-risk patients is crucial and where genomics can inform diagnosis and treatment. But clinical assessment guidelines can be challenging to integrate into clinical practice and it’s difficult for many providers to keep up with the evolving standards of care,” said James Johnson, managing director, MedTech Breakthrough. “The RISE Patient Engagement Module helps to increase access to genetic services and support patient decision-making. RISE modules span the continuum of genetics care including scheduling, hereditary cancer risk assessment, and patient education. Congratulations to Genome Medical on winning this year’s ‘Genomics Innovation Award!’”

Genome Medical employs the largest number of telehealth genetic counselors in the U.S. Since inception, it has completed more than 136,000 patient encounters through its telegenetic counseling services, delivering more than 8,000 patient encounters per month.

About Genome Medical

Genome Medical, the leading telegenetics care delivery company, is making genetic care accessible and actionable for patients through seven-day a week access to genetic services. By partnering with health systems, providers, labs and biopharmaceutical companies, Genome Medical expands the reach and impact of genomic medicine. The company helps its partners deliver clinical risk assessments for patients, genetic test recommendations and ordering, pre and post-test genetic counseling through its team of expert genetic counselors and personalized care plans. Its advisory services team uses an evidence-based approach to help partners evaluate and develop scalable, efficient and successful genetics programs. Headquartered in South San Francisco, Genome Medical has been honored as “The Best Digital Health Company to Work For” by Rock Health and the “Top 50 in Digital Health” by Fenwick & West and Goldman Sachs. To learn more, visit and follow @GenomeMed.

About MedTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit